1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

  • August 2015
  • 144 pages
  • BCC Research
Report ID: 3326180

Summary

Table of Contents

Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.

Highlights
- The U.S. market for biodefense-related rapid pathogen detection devices was valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 to reach $248 million by 2016 and $364 million by 2021.
- Detection devices are projected to grow at a CAGR of 5.2% from $155 million by 2016 to $200 million by 2021.
- The sensors devices market is projected to reach $93 million by 2016. It is projected to increase at a CAGR of 12% and reach $164 million by 2021.

Introduction & Scope

INTRODUCTION

REASONS FOR DOING THE STUDY
The U.S. found itself in the unusual position of being attacked by a foreign entity in 2001, and preparations for such an attack were woefully inadequate. Since then, the U.S. government has given priority to preparations for potential biological attacks by incentivizing industry and academia to develop pathogen identification and treatment products. Pathogenic agents can be viruses, bacteria, fungi, protozoa, parasites, or manufactured toxins. They are able to cause diseases in plants, animals and humans. Pathogens that are harmful to animals and plants are not covered unless they pose eminent danger to humans through consumption. Examples of infectious agents discussed include smallpox, anthrax, plague and tularemia. Another area of pathogen identification includes potentially harmful chemical toxins that are used in biological warfare situations. These include ricin and botulin.

The market for biodefense-related rapid pathogen identification products continues to expand with an emphasis on products that are more portable, easy to use, sensitive and accurate. Multiple assays are being field-tested and used by military personnel, first responders, industry and businesses. The purpose for this report is to provide an overview of the industry and its participants, and project the growth of the market through 2021.

STUDY GOALS AND OBJECTIVES
Biological substances that can be weaponized for either civilian or military destruction are considered biodefense related, and identifying these substances accurately and rapidly is at the heart of this report. Additionally, treatment methods such as vaccines and pharmaceuticals will be discussed. The report concentrates on the U.S. biodefense-related rapid pathogen identification and treatment markets.

This report is intended to:
- Provide an accurate overview of the biological warfare landscape and the infectious agents that could pose the most acute problems.
- Discuss the pathogen identification products currently on the market and their potential for growth.
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Provide an overview of recently issued patents related to biological rapid pathogen identification.
- Include a comprehensive directory of manufacturers of assays, sensors, vaccines and pharmaceuticals used

INTENDED AUDIENCE
This new report on the biodefense-related rapid pathogen identification and treatment market will be a valuable tool for decision makers and manufacturers in biodefense rapid pathogen diagnostic, vaccine and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies and university laboratories will find valuable information on the U.S. biodefense market, and individuals involved in strategic planning, marketing and sales development will appreciate the specificity of the report. Additionally, emphasis on the type of disease, major players in the marketplace, market conditions, and current and projected revenues will be provided.

SCOPE AND FORMAT
The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay,
sensor, vaccine and treatment companies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective and Therapy Market in Brazil

  • August 2017
    11 pages
  • Anti-Infective  

    Therapy  

    Vaccine  

View report >

Anti-Infective Market in the US

  • August 2017
    9 pages
  • Anti-Infective  

  • United States  

View report >

Anti-Infective Market in the UK

  • August 2017
    21 pages
  • Anti-Infective  

    Antibiotic Resi...  

  • United Kingdom  

    Europe  

View report >

Vaccine Market

10 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.